Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis

Abstract Intraperitoneal cellular immunotherapy with CAR-redirected lymphocytes is an intriguing approach to target peritoneal carcinomatosis (PC) from ovarian cancer (OC), which is currently evaluated in clinical trials. PC displays a composite structure with floating tumor cells within ascites and...

Full description

Saved in:
Bibliographic Details
Main Authors: Federica Galvagno, Valeria Leuci, Annamaria Massa, Chiara Donini, Ramona Rotolo, Sonia Capellero, Alessia Proment, Letizia Vitali, Andrea Maria Lombardi, Valentina Tuninetti, Lorenzo D’Ambrosio, Alessandra Merlini, Elisa Vigna, Giorgio Valabrega, Luca Primo, Alberto Puliafito, Dario Sangiolo
Format: Article
Language:English
Published: Springer 2024-11-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Online Access:https://doi.org/10.1007/s00262-024-03860-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571646686265344
author Federica Galvagno
Valeria Leuci
Annamaria Massa
Chiara Donini
Ramona Rotolo
Sonia Capellero
Alessia Proment
Letizia Vitali
Andrea Maria Lombardi
Valentina Tuninetti
Lorenzo D’Ambrosio
Alessandra Merlini
Elisa Vigna
Giorgio Valabrega
Luca Primo
Alberto Puliafito
Dario Sangiolo
author_facet Federica Galvagno
Valeria Leuci
Annamaria Massa
Chiara Donini
Ramona Rotolo
Sonia Capellero
Alessia Proment
Letizia Vitali
Andrea Maria Lombardi
Valentina Tuninetti
Lorenzo D’Ambrosio
Alessandra Merlini
Elisa Vigna
Giorgio Valabrega
Luca Primo
Alberto Puliafito
Dario Sangiolo
author_sort Federica Galvagno
collection DOAJ
description Abstract Intraperitoneal cellular immunotherapy with CAR-redirected lymphocytes is an intriguing approach to target peritoneal carcinomatosis (PC) from ovarian cancer (OC), which is currently evaluated in clinical trials. PC displays a composite structure with floating tumor cells within ascites and solid-like masses invading the peritoneum. Therefore, a comprehensive experimental model is crucial to optimize CAR-cell therapies in such a peculiar environment. Here, we explored the activity of cytokine-induced killer lymphocytes (CIK), redirected by CAR against mesothelin (MSLN-CAR.CIK), within reductionistic 3D models resembling the structural complexity of both liquid and solid components of PC. MSLN-CAR.CIK effectively killed and were functionally efficient against OC targets. In a “floating-like” 3D context with floating OC spheroids, both tumor localization and killing by MSLN-CAR.CIK were significantly boosted by fluid flow. In a “solid-like” context, MSLN-CAR.CIK were recruited through the extracellular matrix on embedded tumor aggregates, with variable kinetics depending on the effector-target distance. Furthermore, MSLN-CAR.CIK penetrated the inner levels of OC spheroids exerting effective tumor killing. Our findings provide currently unknown therapeutically relevant information on intraperitoneal approaches with CAR.CIK, supporting further developments and improvements for clinical studies in the context of locoregional cell therapy approaches for patients with PC from OC.
format Article
id doaj-art-3f8296825a904b688902b192289d96ff
institution Kabale University
issn 1432-0851
language English
publishDate 2024-11-01
publisher Springer
record_format Article
series Cancer Immunology, Immunotherapy
spelling doaj-art-3f8296825a904b688902b192289d96ff2025-02-02T12:26:36ZengSpringerCancer Immunology, Immunotherapy1432-08512024-11-0174111410.1007/s00262-024-03860-wThree-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosisFederica Galvagno0Valeria Leuci1Annamaria Massa2Chiara Donini3Ramona Rotolo4Sonia Capellero5Alessia Proment6Letizia Vitali7Andrea Maria Lombardi8Valentina Tuninetti9Lorenzo D’Ambrosio10Alessandra Merlini11Elisa Vigna12Giorgio Valabrega13Luca Primo14Alberto Puliafito15Dario Sangiolo16Department of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoCandiolo Cancer Institute, FPO-IRCCSDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoDepartment of Oncology, University of TorinoAbstract Intraperitoneal cellular immunotherapy with CAR-redirected lymphocytes is an intriguing approach to target peritoneal carcinomatosis (PC) from ovarian cancer (OC), which is currently evaluated in clinical trials. PC displays a composite structure with floating tumor cells within ascites and solid-like masses invading the peritoneum. Therefore, a comprehensive experimental model is crucial to optimize CAR-cell therapies in such a peculiar environment. Here, we explored the activity of cytokine-induced killer lymphocytes (CIK), redirected by CAR against mesothelin (MSLN-CAR.CIK), within reductionistic 3D models resembling the structural complexity of both liquid and solid components of PC. MSLN-CAR.CIK effectively killed and were functionally efficient against OC targets. In a “floating-like” 3D context with floating OC spheroids, both tumor localization and killing by MSLN-CAR.CIK were significantly boosted by fluid flow. In a “solid-like” context, MSLN-CAR.CIK were recruited through the extracellular matrix on embedded tumor aggregates, with variable kinetics depending on the effector-target distance. Furthermore, MSLN-CAR.CIK penetrated the inner levels of OC spheroids exerting effective tumor killing. Our findings provide currently unknown therapeutically relevant information on intraperitoneal approaches with CAR.CIK, supporting further developments and improvements for clinical studies in the context of locoregional cell therapy approaches for patients with PC from OC.https://doi.org/10.1007/s00262-024-03860-w3D modelsCellular immunotherapyChimeric antigen receptorOvarian cancerPeritoneal carcinomatosis
spellingShingle Federica Galvagno
Valeria Leuci
Annamaria Massa
Chiara Donini
Ramona Rotolo
Sonia Capellero
Alessia Proment
Letizia Vitali
Andrea Maria Lombardi
Valentina Tuninetti
Lorenzo D’Ambrosio
Alessandra Merlini
Elisa Vigna
Giorgio Valabrega
Luca Primo
Alberto Puliafito
Dario Sangiolo
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
Cancer Immunology, Immunotherapy
3D models
Cellular immunotherapy
Chimeric antigen receptor
Ovarian cancer
Peritoneal carcinomatosis
title Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
title_full Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
title_fullStr Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
title_full_unstemmed Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
title_short Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
title_sort three dimensional dynamics of mesothelin targeted car cik lymphocytes against ovarian cancer peritoneal carcinomatosis
topic 3D models
Cellular immunotherapy
Chimeric antigen receptor
Ovarian cancer
Peritoneal carcinomatosis
url https://doi.org/10.1007/s00262-024-03860-w
work_keys_str_mv AT federicagalvagno threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT valerialeuci threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT annamariamassa threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT chiaradonini threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT ramonarotolo threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT soniacapellero threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT alessiaproment threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT letiziavitali threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT andreamarialombardi threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT valentinatuninetti threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT lorenzodambrosio threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT alessandramerlini threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT elisavigna threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT giorgiovalabrega threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT lucaprimo threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT albertopuliafito threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis
AT dariosangiolo threedimensionaldynamicsofmesothelintargetedcarciklymphocytesagainstovariancancerperitonealcarcinomatosis